This was an observational, descriptive, retrospective, single-center study of cases of nephrectomies for non-functional ...

Metroid Prime 4: Beyond not only reinforces that Samus Aran can headline a game in first-person or in side-scrolling form, ...

Novo Nordisk filed an FDA application for weekly CagriSema after trials showed up to 22.7% weight loss versus placebo.

NVO seeks approval for a 7.2 mg Wegovy dose after study data showed stronger weight loss that can challenge Zepbound's U.S.

Lilly has a new pill, called orforglipron, it plans to launch next year. On Thursday, the company reported the results of a ...

The 2026 Toyota RAV4 offers plenty of trims, but only one delivers the best mix of features, value, and capability. Here’s ...

Novo Nordisk’s NDA filing for CagriSema positions the first fixed-dose amylin–GLP-1 combination as a potential ...

More GLP-1s aim to enter US market as Novo Nordisk, Eli Lilly, and Pfizer advance obesity treatments with FDA filings and trials.

Beyond” has had an uncharacteristically troubled development cycle. After it was completely rebooted in 2017, we’ve finally ...

Participants in a Phase III trial who switched to Eli Lilly’s orforglipron after 72 weeks of treatment with Wegovy or ...

Eli Lilly's oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 ...

Metroid Prime 4 is here. It’s finally here. On December 4, 2025, fans around the world rejoiced in unison as they downloaded ...